Eventide Asset Management’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Eventide Asset Management’s Portfolio DCPH Stock Details DCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-400,000	Closed	-$13.6M	–	165
2021 Q3	$13.6M	Buy	+400,000	New	+$12.8M	0.18%	117
2021 Q1	–	Sell	-243,000	Closed	-$13.9M	–	176
2020 Q4	$13.9M	Hold	243,000	–	–	0.21%	102
2020 Q3	$12.5M	Hold	243,000	–	–	0.24%	96
2020 Q2	$14.5M	Hold	243,000	–	–	0.32%	82
2020 Q1	$10M	Buy	+243,000	New	+$13.5M	0.32%	84

Other funds holding DCPH

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Eventide Asset Management's DCPH Position: Q4 2021 in Review

Eventide Asset Management sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q4 2021, closing a stake of 400,000 shares — an estimated $13.6M sold.

Eventide Asset Management first reported a position in DCPH in Q1 2020 and held it in 5 quarters. The position peaked at $14.5M in Q2 2020. 140 funds tracked by Wall St. Rank hold DCPH as of Q4 2021.

Eventide Asset Management reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
Eventide Asset Management sold 400,000 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q4 2021, an estimated $13.6M.
Eventide Asset Management first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q1 2020 and held it in 5 quarters.
Eventide Asset Management's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $14.5M in Q2 2020.
140 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q4 2021.

Based on Eventide Asset Management's 13F filing for Q4 2021, filed 14 Feb 2022.